Gray-market peptide sellers and review sites are increasingly using AI-generated websites, testimonials, and forum posts to appear credible. Peptides are short amino-acid chains that generally must be injected or delivered nasally because digestion breaks them down, and demand for them has created a market of suppliers whose quality and legitimacy can be difficult to verify. Qingdao Sigma, a frequently recommended peptide seller, displays low prices, purported laboratory testing, card payments, and favorable reviews. Its apparent Trustpilot page is hosted on its own site rather than Trustpilot, and the reviews were identified as AI-generated. CompoundTalk, a peptide-review site with a “Verified Vendors” forum, contains AI-generated posts, including a thread about Qingdao Sigma. An analysis using Claude found that CompoundTalk was hosted by Moldova-based AlexHost; listed 20 Chinese raw-peptide vendors; and had recurring data anomalies, including exactly five posts per forum thread, 985 threads dated before the domain registration, and posts predating their supposed authors’ registrations. CompoundTalk and the peptide-analysis site PeptideMeter were registered 13 minutes apart through the same registrar and share the same Cloudflare DNS-server pair. CompoundTalk’s robots.txt explicitly permits LLM crawlers, while the site sells vendor-feature packages and says sponsorship does not affect moderation or reviews. The site’s operator could be seeking visibility in AI-generated recommendations, although that intent is not independently established.
henryaj.substack.com
4 min
8/23/2026
Moderna and Merck announced positive topline Phase 3 results from INTerpath-001, which tested intismeran autogene with KEYTRUDA as an adjuvant treatment for patients with completely resected stage IIB–IV melanoma. Intismeran autogene is an investigational mRNA-based individualized neoantigen therapy jointly developed by the two companies. The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival. Noubar Afeyan, Moderna’s co-founder, said the result marks the first positive Phase 3 outcome for an individualized neoantigen therapy and for an mRNA-based cancer therapy. The therapy is designed around mutations unique to an individual patient’s tumor and is intended to be used alongside KEYTRUDA. Moderna was founded in 2010, when, according to Afeyan, using mRNA as a new class of medicines and as a basis for personalized cancer treatment faced substantial skepticism. Afeyan said important work remains and credited Moderna, Merck, trial investigators, patients, and families for contributing to the milestone.
twitter.com
1 min
8/19/2026
Artificial Intelligence has been successfully used to design 16 novel viruses that can replicate in laboratory conditions and infect bacteria. This marks the first instance of AI designing whole genomes, representing a significant advancement in scientific research.
bbc.co.uk
4 min
8/7/2026
Peptides from the venom of the Tasmanian cave spider and giant Japanese funnel-web spider effectively kill Varroa destructor mites while leaving honeybees unharmed. This research marks a significant advancement in potential treatments for protecting honeybee hives from this deadly parasite.
connectsci.au
2 min
7/9/2026
DNA can be sequenced at home using an Oxford Nanopore Technologies MinION by collecting cheek cells from a swab, preparing them for sequencing, and analyzing the results. Cheek cells are easily accessible and replenish quickly, but they are not suitable for diagnosing conditions like cancer or inflammation.
bradleywoolf.com
15 min
7/7/2026
Craig Venter, a key figure in the Human Genome Project, passed away on April 29th at the age of 79. He was known for his ambitious efforts to decode the human genome and was often seen as a rival to other prominent scientists in the field.
economist.com
1 min
5/2/2026
Gray-market peptide sellers and review sites are increasingly using AI-generated websites, testimonials, and forum posts to appear credible. Peptides are short amino-acid chains that generally must be injected or delivered nasally because digestion breaks them down, and demand for them has created a market of suppliers whose quality and legitimacy can be difficult to verify. Qingdao Sigma, a frequently recommended peptide seller, displays low prices, purported laboratory testing, card payments, and favorable reviews. Its apparent Trustpilot page is hosted on its own site rather than Trustpilot, and the reviews were identified as AI-generated. CompoundTalk, a peptide-review site with a “Verified Vendors” forum, contains AI-generated posts, including a thread about Qingdao Sigma. An analysis using Claude found that CompoundTalk was hosted by Moldova-based AlexHost; listed 20 Chinese raw-peptide vendors; and had recurring data anomalies, including exactly five posts per forum thread, 985 threads dated before the domain registration, and posts predating their supposed authors’ registrations. CompoundTalk and the peptide-analysis site PeptideMeter were registered 13 minutes apart through the same registrar and share the same Cloudflare DNS-server pair. CompoundTalk’s robots.txt explicitly permits LLM crawlers, while the site sells vendor-feature packages and says sponsorship does not affect moderation or reviews. The site’s operator could be seeking visibility in AI-generated recommendations, although that intent is not independently established.
henryaj.substack.com
4 min
8/23/2026
Artificial Intelligence has been successfully used to design 16 novel viruses that can replicate in laboratory conditions and infect bacteria. This marks the first instance of AI designing whole genomes, representing a significant advancement in scientific research.
bbc.co.uk
4 min
8/7/2026
DNA can be sequenced at home using an Oxford Nanopore Technologies MinION by collecting cheek cells from a swab, preparing them for sequencing, and analyzing the results. Cheek cells are easily accessible and replenish quickly, but they are not suitable for diagnosing conditions like cancer or inflammation.
bradleywoolf.com
15 min
7/7/2026
Craig Venter, a key figure in the Human Genome Project, passed away on April 29th at the age of 79. He was known for his ambitious efforts to decode the human genome and was often seen as a rival to other prominent scientists in the field.
economist.com
1 min
5/2/2026
Moderna and Merck announced positive topline Phase 3 results from INTerpath-001, which tested intismeran autogene with KEYTRUDA as an adjuvant treatment for patients with completely resected stage IIB–IV melanoma. Intismeran autogene is an investigational mRNA-based individualized neoantigen therapy jointly developed by the two companies. The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival. Noubar Afeyan, Moderna’s co-founder, said the result marks the first positive Phase 3 outcome for an individualized neoantigen therapy and for an mRNA-based cancer therapy. The therapy is designed around mutations unique to an individual patient’s tumor and is intended to be used alongside KEYTRUDA. Moderna was founded in 2010, when, according to Afeyan, using mRNA as a new class of medicines and as a basis for personalized cancer treatment faced substantial skepticism. Afeyan said important work remains and credited Moderna, Merck, trial investigators, patients, and families for contributing to the milestone.
twitter.com
1 min
8/19/2026
Peptides from the venom of the Tasmanian cave spider and giant Japanese funnel-web spider effectively kill Varroa destructor mites while leaving honeybees unharmed. This research marks a significant advancement in potential treatments for protecting honeybee hives from this deadly parasite.
connectsci.au
2 min
7/9/2026
Equine cloning has become a mature industry in Argentina's polo scene, with cloned horses now commonly used. Ethical dilemmas surrounding the practice continue to be a topic of discussion.
knowablemagazine.org
15 min
6/7/2026
Gray-market peptide sellers and review sites are increasingly using AI-generated websites, testimonials, and forum posts to appear credible. Peptides are short amino-acid chains that generally must be injected or delivered nasally because digestion breaks them down, and demand for them has created a market of suppliers whose quality and legitimacy can be difficult to verify. Qingdao Sigma, a frequently recommended peptide seller, displays low prices, purported laboratory testing, card payments, and favorable reviews. Its apparent Trustpilot page is hosted on its own site rather than Trustpilot, and the reviews were identified as AI-generated. CompoundTalk, a peptide-review site with a “Verified Vendors” forum, contains AI-generated posts, including a thread about Qingdao Sigma. An analysis using Claude found that CompoundTalk was hosted by Moldova-based AlexHost; listed 20 Chinese raw-peptide vendors; and had recurring data anomalies, including exactly five posts per forum thread, 985 threads dated before the domain registration, and posts predating their supposed authors’ registrations. CompoundTalk and the peptide-analysis site PeptideMeter were registered 13 minutes apart through the same registrar and share the same Cloudflare DNS-server pair. CompoundTalk’s robots.txt explicitly permits LLM crawlers, while the site sells vendor-feature packages and says sponsorship does not affect moderation or reviews. The site’s operator could be seeking visibility in AI-generated recommendations, although that intent is not independently established.
henryaj.substack.com
4 min
8/23/2026
Peptides from the venom of the Tasmanian cave spider and giant Japanese funnel-web spider effectively kill Varroa destructor mites while leaving honeybees unharmed. This research marks a significant advancement in potential treatments for protecting honeybee hives from this deadly parasite.
connectsci.au
2 min
7/9/2026
Craig Venter, a key figure in the Human Genome Project, passed away on April 29th at the age of 79. He was known for his ambitious efforts to decode the human genome and was often seen as a rival to other prominent scientists in the field.
economist.com
1 min
5/2/2026
Moderna and Merck announced positive topline Phase 3 results from INTerpath-001, which tested intismeran autogene with KEYTRUDA as an adjuvant treatment for patients with completely resected stage IIB–IV melanoma. Intismeran autogene is an investigational mRNA-based individualized neoantigen therapy jointly developed by the two companies. The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival. Noubar Afeyan, Moderna’s co-founder, said the result marks the first positive Phase 3 outcome for an individualized neoantigen therapy and for an mRNA-based cancer therapy. The therapy is designed around mutations unique to an individual patient’s tumor and is intended to be used alongside KEYTRUDA. Moderna was founded in 2010, when, according to Afeyan, using mRNA as a new class of medicines and as a basis for personalized cancer treatment faced substantial skepticism. Afeyan said important work remains and credited Moderna, Merck, trial investigators, patients, and families for contributing to the milestone.
twitter.com
1 min
8/19/2026
DNA can be sequenced at home using an Oxford Nanopore Technologies MinION by collecting cheek cells from a swab, preparing them for sequencing, and analyzing the results. Cheek cells are easily accessible and replenish quickly, but they are not suitable for diagnosing conditions like cancer or inflammation.
bradleywoolf.com
15 min
7/7/2026
Artificial Intelligence has been successfully used to design 16 novel viruses that can replicate in laboratory conditions and infect bacteria. This marks the first instance of AI designing whole genomes, representing a significant advancement in scientific research.
bbc.co.uk
4 min
8/7/2026
No more articles to load